Lefamulin’s mechanism of action has a low inclination for developing resistance. The drug is a member of the pleuromutilin antibiotic class, and it has low propensity for cross resistance with a variety of antibiotic classes such as macrolide and tetracycline.
In August 2019, the CDC released an update on antibiotic use in the United States. The update includes data on antibiotic stewardship programs and resources, from 2018 studies. The CDC is continuously working to improve antibiotic prescribing and use as a part of the Antibiotic Resistance Solutions Initiative.
In “From Theory to Practice with Faster Diagnostics: It Takes a Team,” Ravina Kullar, PharmD, MPH, FIDSA, will review the burden of antimicrobial resistance and the importance of early targeted antimicrobial therapy.
Each year, doctors in the U.S. perform more than 4 billion diagnostic tests, which have become more sophisticated and easier to execute as technology has improved. However, research has found that many physicians assume tests are more accurate than they are.